Please login to the form below

variants

This page shows the latest variants news and features for those working in and with pharma, biotech and healthcare.

JCVI recommends spring COVID-19 booster for those at highest risk

It has also recently outlined that an emergency surge vaccine response may be required if a new variant of concern emerges that has clinically significant biological differences from the Omicron variant.

Latest news

Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children

Vaccine manufacturers have been focused on the development of variant specific boosters since the World Health Organization recommended that COVID-19 vaccines be reworked to ensure they are effective against Omicron ... and future variants.
WHO announces recommended 2023-24 flu vaccines for northern hemisphere

Review the antigenic and genetic characteristics of other recent subtype or variant influenza and the need to develop new candidate vaccine viruses for pandemic preparedness purposes.
Gilead reports positive real-world evidence for COVID-19 treatment Veklury

a statistically significant lower risk for mortality in all oxygen levels across all variant time periods.
NICE publishes final draft guidance recommending three COVID-19 treatments

Although the majority of the clinical evidence that is available for NICE to review is based on studies done before the emergence of the Omicron variant, the three treatments are recommended ... This will enable treatments to be made available to
AstraZeneca’s Evusheld not recommended by NICE for COVID-19 prevention

The agency said there is not enough evidence of the drug’s effectiveness against current variants. ... regulator also citing insufficient evidence of the drug’s ability to protect against dominant variants in the US.

More from news
Approximately 23 fully matching, plus 328 partially matching documents found.

Latest Intelligence

Mental health post-COVID-19: what are the consequences and lessons learned for healthcare?

Surveillance to track new variants of the SARS- CoV-2 virus and other pathogens is critical to limit virus transmission and the need for further public health restrictions that may trigger
Customers, content and change

variant. From personalisation to hyper-personalisation. Another perspective on customer engagement was provided by Lutz Bonacker, senior vice president and general manager for Commercial Operations Europe at CSL Behring.
Mastering oneself

Frequently, we have more information than we can easily process. System 1 heuristics offer to help us by focusing on the most recent or salient information – a variant of what Kahneman
Back to the future

I told them it would be speciation. Evolutionary forces like the six great shifts don’t change one entity into another, they cause it to divide into variants.
AI and accelerated computing ring in new era for healthcare

Its nanopore sequencing devices have been used in more than 50 countries to sequence and track new variants of the virus that causes COVID-19, as well as for large-scale ... Through deep learning, the base calling model is able to reach an overall

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

Galenica Group strengthens management team

We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

What does the future hold for clinical trial recruitment?

This work is ongoing as the virus mutates; last month, it was announced that Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant.
Top 10 things to consider when designing hybrid meetings

Although the Omicron variant of COVID-19 might have set back the full return to in-person meetings for now, there is no doubt that the future is hybrid.
How to innovate and influence people in times of misinformation

vaccination effort, which left us more vulnerable to Delta-driven COVID surges in the summer and fall of 2021, as well as the Omicron variant that showed up toward the end
NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE

2022. With an NHS at breaking point and new COVID variants threatening to hit reverse on the progress made in our pandemic response, it’s fair to say that 2022 is
Women’s 2021 health wins worth celebrating

progress. With all the negative health news in 2021 related to new variants of Covid and NHS waiting lists and vacancies reaching record highs, Thrive agency wanted to focus on the

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

Subscribe to our email news alerts

Omnichannel Account Director: £55,000 - £65,000 yearly

Senior Medical Writer: Highly competitive salary

Pharmacovigilance Project Lead: Highly competitive salary

Strategy Director - Healthcare Advertising: £90,000 - £120,000 yearly

Early Access Program - Regulatory Affairs (EAP-RA): Highly competitive salary

Associate Director - Global Healthcare Consulting: £100,000 - £115,000 yearly

Technical Sales Representative: Highly competitive salary

Pharmacovigilance Manager: Highly competitive salary

PMHub

Add my company

Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Time to talk about health inequalities: Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
The speed of science and the pace of comms: Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness: Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...

Email:
Password:

Please login to the form below

variants

Subscribe to our email news alerts

Quick links